New York, New York--(Newsfile Corp. - February 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.SO WHAT: If you purchased agilon securities during the Class Period you may be entitled to compensation without payment of any ou ...

Core Insights - IDEAYA Biosciences has initiated a Phase 1 trial for IDE034, a bispecific TOP1 ADC targeting B7H3/PTK7, which is co-expressed in 30-40% of various solid tumors, including lung, breast, ovarian, and colorectal cancers [1] - The trial aims to evaluate the safety, tolerability, and pharmacokinetics of IDE034, both as a monotherapy and in combination with the proprietary PARG inhibitor, IDE161 [1] - The first patient dosing triggers a $5 million milestone payment to Biocytogen, highlighting the collaboration between the two companies [1] Company Overview - IDEAYA Biosciences is focused on precision medicine in oncology, aiming to develop transformative therapies for cancer through a combination of small-molecule drug discovery, structural biology, and bioinformatics [1] - The company has a robust pipeline of product candidates, particularly in synthetic lethality and antibody-drug conjugates (ADCs), targeting molecularly defined solid tumor indications [1] - IDE034 represents the second proprietary TOP1 ADC from IDEAYA, following IDE849, which is currently in Phase 1 for small cell lung cancer (SCLC) and neuroendocrine carcinoma (NEC) [1] Clinical Development - The Phase 1 trial will assess IDE034's potential as a first-in-class therapy, with preclinical models showing promising efficacy and synergy when combined with IDE161 [1] - The design of IDE034 allows for internalization only when both target antigens are present on the same tumor cell, potentially enhancing selectivity and tolerability compared to traditional antibody formats [1] - IDEAYA estimates minimal dual antigen expression in normal tissues, which may further improve the therapeutic profile of IDE034 [1]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Smart Digital Group Ltd. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased SDM securities between May 5, 2025, and September 26, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 16, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]. Group 3: Case Allegations - The lawsuit alleges that Smart Digital was involved in a market manipulation scheme, including social media misinformation and impersonation of financial professionals [5]. - It is claimed that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, and that the company's public statements omitted risks related to fraudulent trading [5]. - As a result of these actions, Smart Digital securities faced the risk of trading suspension by the SEC and NASDAQ, leading to misleading statements about the company's business and operations [5].

Core Points - Rosen Law Firm is reminding purchasers of CoreWeave, Inc. securities from March 28, 2025, to December 15, 2025, about the lead plaintiff deadline on March 13, 2026 [1] - Investors who purchased CoreWeave securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed against CoreWeave, and interested parties can join by contacting Rosen Law Firm [2] Case Details - The lawsuit alleges that CoreWeave's defendants made false and misleading statements regarding the company's ability to meet customer demand and the risks associated with reliance on a single third-party data center supplier [4] - It is claimed that these misstatements were likely to have a material negative impact on CoreWeave's revenue, leading to damages for investors when the truth was revealed [4] Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “Class Period”), of the important April 13, 2026 lead plaintiff deadline. SO WHAT: If you purchased uniQure ordinary shares during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

Core Viewpoint - Rosen Law Firm is reminding sellers of Masonite International Corporation common stock about a class action lawsuit related to material omissions and misrepresentations during the Class Period from June 5, 2023, to February 8, 2024, with a lead plaintiff deadline of April 7, 2026 [1][4]. Group 1: Class Action Details - Investors who sold Masonite common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. - The lawsuit alleges that Masonite made significant omissions regarding Owens Corning's offers to purchase its stock at premiums, which misled investors about the true value of Masonite's shares [4]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, as many firms may not have the necessary experience [3]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its leadership in securities class action settlements [3].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Apollo Global Management, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by an article from Financial Times stating that Apollo executives, including CEO Marc Rowan, had discussions regarding tax arrangements with Jeffrey Epstein, despite previous claims of no business dealings with him [3]. - Following the news, Apollo's stock experienced a decline of 1% on February 2, 2026, and a further drop of 4.76% on February 3, 2026 [3]. Group 2: Class Action Information - Shareholders who purchased Apollo securities may be eligible for compensation through a class action lawsuit without any out-of-pocket fees, facilitated by a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4].

Group 1 - A class action lawsuit has been announced by Rosen Law Firm on behalf of purchasers of Class A common stock of NuScale Power Corporation (NYSE: SMR) during the Class Period from May 13, 2025, to November 6, 2025 [1] - Investors who purchased NuScale Class A common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - The lawsuit alleges that NuScale made false and misleading statements regarding its partnership with ENTRA1 Energy LLC, which lacked significant experience in nuclear power generation, exposing NuScale's commercialization strategy to undisclosed risks [5] Group 2 - To join the NuScale class action, interested parties can visit the provided link or contact Phillip Kim, Esq. for more information [3][6] - The Rosen Law Firm has a strong track record in securities class actions, having recovered hundreds of millions of dollars for investors and being recognized for its success in this field [4] - No class has been certified yet, and investors are advised that they are not represented by counsel unless they retain one [7]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Smart Digital Group Ltd. (NASDAQ: SDM) between May 5, 2025, and September 26, 2025, of the upcoming lead plaintiff deadline on March 16, 2026 [1] Group 1: Class Action Details - Investors who purchased SDM securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - To serve as lead plaintiff, individuals must file a motion with the Court by March 16, 2026 [3] Group 2: Case Allegations - The lawsuit alleges that Smart Digital was involved in a market manipulation and fraudulent promotion scheme, including misinformation on social media and impersonation of financial professionals [5] - It is claimed that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign [5] - The public statements and risk disclosures from Smart Digital allegedly omitted critical information regarding the risks of fraudulent trading and market manipulation, leading to misleading representations about the company's business and prospects [5]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Nidec Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased Nidec securities, with no out-of-pocket fees through a contingency fee arrangement [2]. - The investigation follows a significant drop in Nidec's stock price, which fell 22.7% after a probe into accounting issues was announced [3]. Group 2: Company Background and Legal Expertise - Nidec Corporation is facing scrutiny due to allegations of improper accounting practices within its group, leading to the largest one-day drop in its shares [3]. - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and recovering hundreds of millions for investors [4].